Abstract

Background: Pseudomonas aeruginosa is the causing agent of many hospital infections and metallo-beta-lactamases (MBL) are being reported with increasing frequency. The aim of this study was to determine t he frequency of metallo-βlactamases (MBL) and VIM-1 gene in multidrug-resistant strains of P. aeruginosa isolates and to compare the methods of phenotypic a nd molecular detection. Materials and Methods : In 2011- 2012, 50 samples of non ‐ duplicate P. aeruginosa were isolated from intensive care units and tested for MBL production using phenotypic methods. Minimal Inhibitory concentrations (MICs) were determined by commercial micro dilution panels. The presence of metallo-βlactamase (MBL) genes was established by polymerase chain reaction (PCR) with specific primers targeting the bla (VIM) genes. Results : We used 50 clinical isolates amongst which 18 (%3 6) were found resistant to imipenem. Productions of MBL were detected in 15 (30%) isolates applying phenotypic method. PCR assay showed that 9 (18%) isolates carried aVIM-1 gene. MBL- producing strains were shown 100% resistant to cefepime, ceftazidime, ceftriaxone, cefotaxime and imipenem. Amikacin and ofloxacin appeared to be the most active antimicrobial agent. Conclusion: These findings demonstrate the emergence of bla (VIM-1) producing P. aeruginosa in North of Iran. VIM metallo-beta-lactamases producing P. aeruginosa strains can cause serious infections that are diffi cult to treat, therefore, there is a need for rapid identification and the ti mely implementation of infection control measures in combination with systematic sur veillance to monitor its potential clonal spread.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.